Literature DB >> 18067967

Arteriolar oxygen saturation, cerebral blood flow, and retinal vessel diameters. The Rotterdam Study.

Frank Jan de Jong1, Meike W Vernooij, M Kamran Ikram, M Arfan Ikram, Albert Hofman, Gabriel P Krestin, Aad van der Lugt, Paulus T V M de Jong, Monique M B Breteler.   

Abstract

OBJECTIVE: Retinal vessel diameters, in particular larger venular diameters, have been associated with cerebrovascular disease. Larger retinal venular diameters may reflect cerebral ischemia. The authors investigated whether arteriolar oxygen saturation (SaO2) and total cerebral blood flow (CBF), indicators of cerebral oxygen supply, are associated with retinal arteriolar or venular diameters.
DESIGN: Cross-sectional study performed within the population-based Rotterdam Study. PARTICIPANTS: Randomly selected participants aged 55 years or older (n = 696), who underwent both an eye examination and brain magnetic resonance imaging (MRI).
METHODS: Arteriolar oxygen saturation was determined by pulse oximetry on the right index finger. Cerebral blood flow was assessed using a phase-contrast MRI sequence that measured the flow in the basilar and both internal carotid arteries. Brain volume was measured to express CBF per 100 ml brain volume. Retinal arteriolar and venular diameters were measured on digitized fundus color transparencies on 1 eye of each participant. Regression models were used to investigate the association of SaO(2) and CBF with retinal vessel diameters. MAIN OUTCOME MEASURES: Mean retinal arteriolar and venular diameters (in micrometers).
RESULTS: Lower SaO2 was associated with larger venular diameters. Persons with SaO(2) less than 96% (n = 113) had on average 5 microm larger venular diameters compared with those with SaO(2) of 96% or more (n = 583; age- and gender-adjusted mean difference, 5.6 microm; 95% confidence interval, 1.2-10.0). Cerebral blood flow was not related to venular diameters when analyzed separately. Additional analyses showed that the association between SaO(2) and venular widening was confined to participants within the lowest tertile of CBF. No associations were found between SaO(2) or CBF and arteriolar diameters. Additional adjustment for established cardiovascular risk factors did not change the results.
CONCLUSIONS: An association of lower SaO(2) with larger retinal venular diameters was observed, in particular in the presence of lower CBF. These findings suggest that venular widening may reflect a lower oxygen supply, especially to the brain.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18067967     DOI: 10.1016/j.ophtha.2007.06.036

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  24 in total

1.  Retinal vascular caliber and risk of dementia: the Rotterdam study.

Authors:  F J de Jong; E M C Schrijvers; M K Ikram; P J Koudstaal; P T V M de Jong; A Hofman; J R Vingerling; M M B Breteler
Journal:  Neurology       Date:  2011-02-02       Impact factor: 9.910

2.  Complete blood cell count and retinal vessel diameters.

Authors:  Barbara E K Klein; Ronald Klein; Chelsea E Myers; Kristine E Lee
Journal:  Arch Ophthalmol       Date:  2011-04

3.  Shiftwork and the Retinal Vasculature Diameters Among Police Officers.

Authors:  Luenda E Charles; Ja K Gu; Claudia C Ma; Lisa M Grady; Anna Mnatsakanova; Michael E Andrew; Desta Fekedulegn; John M Violanti; Ronald Klein
Journal:  J Occup Environ Med       Date:  2017-10       Impact factor: 2.162

4.  Association between physical activity and retinal microvascular signs: the Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Gabriella Tikellis; Satyamurthy Anuradha; Ronald Klein; Tien Yin Wong
Journal:  Microcirculation       Date:  2010-07       Impact factor: 2.628

5.  The Study of Neurocognitive Outcomes, Radiological and Retinal Effects of Aspirin in Sleep Apnoea- rationale and methodology of the SNORE-ASA study.

Authors:  Stephanie Alison Ward; Elsdon Storey; Robyn L Woods; Garun S Hamilton; Ryo Kawasaki; Andrew L Janke; Matthew T Naughton; Fergal O'Donoghue; Rory Wolfe; Tien Y Wong; Christopher M Reid; Walter P Abhayaratna; Nigel Stocks; Ruth Trevaks; Sharyn Fitzgerald; Lauren A B Hodgson; Liubov Robman; Barbara Workman; John J McNeil
Journal:  Contemp Clin Trials       Date:  2017-10-31       Impact factor: 2.226

6.  Retinal microvessels reflect familial vulnerability to psychotic symptoms: A comparison of twins discordant for psychotic symptoms and controls.

Authors:  Madeline H Meier; Nathan A Gillespie; Narelle K Hansell; Alex W Hewitt; Ian B Hickie; Yi Lu; John McGrath; Stuart MacGregor; Sarah E Medland; Cong Sun; Tien Y Wong; Margaret J Wright; Gu Zhu; Nicholas G Martin; David A Mackey
Journal:  Schizophr Res       Date:  2015-02-16       Impact factor: 4.939

7.  Relative importance of systemic determinants of retinal arteriolar and venular caliber: the atherosclerosis risk in communities study.

Authors:  Gerald Liew; A Richey Sharrett; Jie Jin Wang; Ronald Klein; Barbara E K Klein; Paul Mitchell; Tien Y Wong
Journal:  Arch Ophthalmol       Date:  2008-10

8.  Quantification of biological aging in young adults.

Authors:  Daniel W Belsky; Avshalom Caspi; Renate Houts; Harvey J Cohen; David L Corcoran; Andrea Danese; HonaLee Harrington; Salomon Israel; Morgan E Levine; Jonathan D Schaefer; Karen Sugden; Ben Williams; Anatoli I Yashin; Richie Poulton; Terrie E Moffitt
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-06       Impact factor: 11.205

9.  Admixture mapping scans identify a locus affecting retinal vascular caliber in hypertensive African Americans: the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Ching-Yu Cheng; David Reich; Tien Y Wong; Ronald Klein; Barbara E K Klein; Nick Patterson; Arti Tandon; Man Li; Eric Boerwinkle; A Richey Sharrett; W H Linda Kao
Journal:  PLoS Genet       Date:  2010-04-15       Impact factor: 5.917

10.  Differences in retinal vessels support a distinct vasculopathy causing lacunar stroke.

Authors:  F N Doubal; T J MacGillivray; P E Hokke; B Dhillon; M S Dennis; J M Wardlaw
Journal:  Neurology       Date:  2009-05-19       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.